Literature DB >> 8570436

Analysis of various creatinine clearance formulas in predicting gentamicin elimination in patients with low serum creatinine.

R M Reichley1, D J Ritchie, T C Bailey.   

Abstract

Predicted gentamicin elimination rate constants (kelS) using creatinine clearance (Clcr) estimates from seven equations were compared with kelS calculated from steady-state serum gentamicin concentrations in 186 hospitalized patients. In predicting kel, the equations varied significantly in precision (mean absolute percentage error), and were particularly imprecise among patients with serum creatinine values of 71 mumol/L or less. Significant differences in bias (mean prediction error) were also observed. All equations using serum creatinine as an element showed improved precision, and most showed reduced bias when a minimum value of 71 mumol/L was used. The Cockcroft-Gault normalized to 72 kg and the Hull equations are among the simplest to calculate and, when using a minimum serum creatinine of 71 mumol/L, had significantly greater precision and less bias than several of the equations. We recommend one of these two methods for predicting gentamicin kel in patients with low serum creatinine values.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570436     DOI: 10.1002/j.1875-9114.1995.tb02873.x

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

1.  Renal function overestimation in underweight and/or non-ambulatory patients.

Authors:  Fazlollah Keshavarzi
Journal:  Int J Clin Pharm       Date:  2015-07-15

Review 2.  Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly.

Authors:  E Triggs; B Charles
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

3.  Impact of Recent Acute Kidney Injury on Creatinine Clearance Estimation in Critically Ill Patients Undergoing Cardiac Surgery.

Authors:  Amaris Fuentes; Jagadeswara R Earla; Tomona Iso; Joshua T Swan
Journal:  Tex Heart Inst J       Date:  2022-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.